No Data
H.C. Wainwright Initiates Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Announces Target Price $80
H.C. Wainwright analyst Andres Y. Maldonado initiates coverage on $Corbus Pharmaceuticals(CRBP.US)$ with a buy rating, and sets the target price at $80.According to TipRanks data, the analyst has a
Express News | HC Wainwright & Co. Reinstates Buy on Corbus Pharmaceuticals, Announces $80 Price Target
Buy Rating Affirmed: Corbus Pharmaceuticals' Promising Drug Pipeline and Growth Potential
Express News | Corbus Pharmaceuticals Holdings Inc : H.c. Wainwright Resumes Coverage With Buy Rating; Price Target $80
Marijuana Stock Movers For July 19, 2024
GAINERS:Green Growth Brands (OTC:GGBXF) shares closed up 9900.00% at $0.0001Rocky Mountain High (OTC:RMHB) shares closed up 33.33% at $0.02SOL Glb Inv (OTC:SOLCF) shares closed up 19.57% at $0.05
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ:WGS) has made the biggest gains on the Russell 2000 Index in 2024 as the biotechnology company moves toward more comprehensive genetic testing.The Maryland-based company'
Mars MoooOP :![](https://emoticon.futunn.com/rich_daily_life/O_33.png)